🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the efficacy, safety and tolerability of AFQ056 when...
Status
Terminated
Location
Novartis Investigator Site
Start Date
2009-11
Trial ID
NCT01019473
This study will assess the safety and tolerability of oral single dose appl...
Status
Completed
Location
Novartis Investigative site
Start Date
2006-08
Trial ID
NCT00414856
Treatments Being Tested
This study will assess the efficacy and safety of AFQ056 in patients that h...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-11
Trial ID
NCT01385592
The purpose of this pilot study is to evaluate the role of Mavoglurant in c...
Status
Completed
Location
Hartford Hospital
Start Date
2018-06-01
Trial ID
NCT03341715
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of AFQ056 an...
Status
Completed
Location
Novartis Investigative Site
Start Date
2006-09
Trial ID
NCT00414752
Treatments Being Tested
This study assessed whether AFQ056 had a beneficial effect by reducing coca...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-12-04
Trial ID
NCT03242928
The aim of this study was to characterize the pharmacokinetics and safety o...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-01
Trial ID
NCT01442259
Treatments Being Tested
This study is to evaluate long-term safety, tolerability and efficacy for A...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-03
Trial ID
NCT01491932
Treatments Being Tested
This study will assess the pharmacokinetics of AFQ056 in subjects with mild...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-05
Trial ID
NCT01456663
Treatments Being Tested
This study will evaluate the safety and efficacy of administration of AFQ05...
Status
Completed
Location
Novartis Investigator Site
Start Date
2007-10
Trial ID
NCT00582673